Cash & equivalents decreased 38.0%
Cash & equivalents changed -38.0% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -38.0% from the comparable as-filed period.
Debt changed -32.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Gross profit changed +40.1% from the comparable as-filed period.
Inventory changed +170.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Net income changed +1579.4% from the comparable as-filed period.
Operating income changed +416.7% from the comparable as-filed period.
Operating margin changed +759 basis points from the comparable as-filed period.
Revenue changed +47.6% from the comparable as-filed period.
Gross margin changed -150 basis points from the comparable as-filed period.
Research & development changed +8.7% from the comparable as-filed period.
Selling, general & administrative changed -0.5% from the comparable as-filed period.
Stock-based compensation changed -2.5% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.